M J Serlin

978 total citations
17 papers, 712 citations indexed

About

M J Serlin is a scholar working on Pharmacology, Cardiology and Cardiovascular Medicine and Surgery. According to data from OpenAlex, M J Serlin has authored 17 papers receiving a total of 712 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Pharmacology, 5 papers in Cardiology and Cardiovascular Medicine and 4 papers in Surgery. Recurrent topics in M J Serlin's work include Vitamin K Research Studies (4 papers), Pharmacology and Obesity Treatment (4 papers) and Pharmacogenetics and Drug Metabolism (3 papers). M J Serlin is often cited by papers focused on Vitamin K Research Studies (4 papers), Pharmacology and Obesity Treatment (4 papers) and Pharmacogenetics and Drug Metabolism (3 papers). M J Serlin collaborates with scholars based in United Kingdom. M J Serlin's co-authors include R. Sibeon, A Breckenridge, AM Breckenridge, A Breckenridge, Michael Orme, J. D. Baty, P. J. Lewis, Michael de Swiet, M Bruce MacIver and N. Baber and has published in prestigious journals such as The Lancet, British Journal of Pharmacology and Clinical Pharmacology & Therapeutics.

In The Last Decade

M J Serlin

17 papers receiving 609 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
M J Serlin United Kingdom 11 234 213 171 118 111 17 712
A Breckenridge United Kingdom 17 326 1.4× 242 1.1× 92 0.5× 112 0.9× 100 0.9× 57 1.1k
R. Sibeon United Kingdom 12 126 0.5× 142 0.7× 178 1.0× 104 0.9× 95 0.9× 20 534
B. Kaufmann Germany 14 68 0.3× 247 1.2× 107 0.6× 27 0.2× 54 0.5× 29 650
Bruce S. Gillies United States 8 240 1.0× 72 0.3× 46 0.3× 63 0.5× 63 0.6× 14 660
Vincent F. Mauro United States 16 104 0.4× 173 0.8× 66 0.4× 44 0.4× 32 0.3× 45 735
Margareth Gabrielsson Sweden 7 86 0.4× 103 0.5× 53 0.3× 56 0.5× 27 0.2× 10 348
Katrin Coboeken Germany 14 163 0.7× 105 0.5× 142 0.8× 65 0.6× 78 0.7× 22 701
Kirstin Thelen Germany 20 386 1.6× 156 0.7× 186 1.1× 111 0.9× 156 1.4× 26 1.3k
Kristin D. Marciante United States 15 194 0.8× 114 0.5× 62 0.4× 52 0.4× 76 0.7× 17 766
Masayuki Hashiguchi Japan 16 100 0.4× 163 0.8× 71 0.4× 44 0.4× 34 0.3× 64 936

Countries citing papers authored by M J Serlin

Since Specialization
Citations

This map shows the geographic impact of M J Serlin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by M J Serlin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites M J Serlin more than expected).

Fields of papers citing papers by M J Serlin

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by M J Serlin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by M J Serlin. The network helps show where M J Serlin may publish in the future.

Co-authorship network of co-authors of M J Serlin

This figure shows the co-authorship network connecting the top 25 collaborators of M J Serlin. A scholar is included among the top collaborators of M J Serlin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with M J Serlin. M J Serlin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
1.
Chan, Elaine, Leon Aarons, M J Serlin, AM Breckenridge, & Malcolm Rowland. (1987). Inter‐relationship among individual vitamin K‐dependent clotting factors at different levels of anticoagulation.. British Journal of Clinical Pharmacology. 24(5). 621–625. 17 indexed citations
2.
Serlin, M J, et al.. (1983). The pharmacodynamics and pharmacokinetics of conventional and long‐ acting propranolol in patients with moderate hypertension.. British Journal of Clinical Pharmacology. 15(5). 519–527. 28 indexed citations
3.
Serlin, M J & A Breckenridge. (1983). Drug Interactions with Warfarin. Drugs. 25(6). 610–620. 92 indexed citations
4.
Breckenridge, AM, et al.. (1982). Labetalol in essential hypertension.. British Journal of Clinical Pharmacology. 13(S1). 9 indexed citations
5.
Orme, Michael, et al.. (1981). Efficacy and Adverse Effects of Captopril in Severe Refractory Hypertension. Journal of Cardiovascular Pharmacology. 3(6). 1287–1295. 6 indexed citations
6.
Serlin, M J, R. Sibeon, & AM Breckenridge. (1981). Lack of effect of ranitidine on warfarin action.. British Journal of Clinical Pharmacology. 12(6). 791–794. 44 indexed citations
7.
Serlin, M J, et al.. (1980). The effect of diflunisal on the steady state pharmacodynamics and pharmacokinetics of warfarin [proceedings]. British Journal of Clinical Pharmacology. 9(3). 287P–288P. 5 indexed citations
8.
Serlin, M J, et al.. (1980). Propranolol in the control of blood pressure: A dose-response study. Clinical Pharmacology & Therapeutics. 27(5). 586–592. 30 indexed citations
9.
Serlin, M J. (1979). CIMETIDINE: INTERACTION WITH ORAL ANTICOAGULANTS IN MAN. The Lancet. 314(8138). 317–319. 251 indexed citations
10.
Stafford, James E., John Shelton, R. F. Palmer, et al.. (1979). Bioavailability and pharmacokinetics of norethisterone in women after oral doses of ethynodiol diacetate. Contraception. 19(2). 119–127. 12 indexed citations
11.
Serlin, M J, et al.. (1979). Rate of onset of hypotensive effect of oral labetalol.. British Journal of Clinical Pharmacology. 7(2). 165–168. 14 indexed citations
12.
Breckenridge, AM, et al.. (1979). Cimetidine increases the action of warfarin in man [proceedings]. British Journal of Clinical Pharmacology. 8(4). 392P–393P. 20 indexed citations
13.
Serlin, M J. (1979). Antimicrobial drug interactions with oral anticoagulants. Journal of Antimicrobial Chemotherapy. 5(6). 628–630. 2 indexed citations
14.
Breckenridge, A, et al.. (1978). ウサギにおける抗凝固薬,ワルファリン,2-クロロ-3-フィチルナフトキノン(Cl-K),アセノクマロール,ブロジファコウムおよびジフェナコウムの作用機序. British Journal of Pharmacology. 64(3). 399. 2 indexed citations
15.
Breckenridge, A, et al.. (1978). Mechanisms of action of the anticoagulants warfarin, 2-chloro-3-phytylnaphthoquinone (Cl-K), acenocoumarol, brodifacoum and difenacoum in the rabbit [proceedings].. PubMed. 64(3). 399P–399P. 11 indexed citations
16.
Orme, Michael, P. J. Lewis, M J Serlin, et al.. (1978). MAY MOTHERS GIVEN WARFARIN BREAST-FEED THEIR INFANTS?. Obstetrical & Gynecological Survey. 33(1). 22–22. 7 indexed citations
17.
Orme, Michael, P. J. Lewis, Michael de Swiet, et al.. (1977). May mothers given warfarin breast-feed their infants?. BMJ. 1(6076). 1564–1565. 162 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026